Drug profile · INN
interferon alfacon-1
INFERGEN
interferon alfacon-1 (INFERGEN) is a interferon alpha/beta receptor agonist.
EMA: withdrawn Antineoplastic and immunomodulating agents (L03) L03AB09
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — interferon alfacon-1
- Class
- Antineoplastic and immunomodulating agents (L03)
- Route
- —
- Patents
- 1
- Programs
- 0
- Data quality
- 0.83
Quick answer
interferon alfacon-1 (INFERGEN) is a interferon alpha/beta receptor agonist.
Key facts
INN interferon alfacon-1
Brand INFERGEN
Mechanism Interferon alpha/beta receptor agonist
Target Interferon alpha/beta receptor
Therapeutic class Antineoplastic and immunomodulating agents (L03)
ATC code L03AB09
Mechanism of action
Interferon alpha/beta receptor agonist
Primary target: Interferon alpha/beta receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is interferon alfacon-1?
interferon alfacon-1 (INFERGEN) is a interferon alpha/beta receptor agonist.
What is the brand name for interferon alfacon-1?
INFERGEN is a marketed brand name for interferon alfacon-1. Check FDA Drugs@FDA for the current US label holder and prescribing information.